levodopa has been researched along with Lymph Node Metastasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonenkamp, JJ; Wobbes, T | 1 |
Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N | 1 |
Modigliani, E | 1 |
3 other study(ies) available for levodopa and Lymph Node Metastasis
Article | Year |
---|---|
[Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
Topics: Aged; Antiparkinson Agents; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Leg; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Melanins; Melanoma, Amelanotic; Parkinson Disease; Skin Neoplasms | 2002 |
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.
Topics: Adult; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, High Pressure Liquid; Female; Humans; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Prognosis; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine | 2003 |
Medullary thyroid carcinoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Bromocriptine; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pheochromocytoma; Recurrence; Survival Rate; Thyroid Neoplasms; Thyroidectomy | 1994 |